Initial investment in Cellerix, founded in 2004. Cellerix was a biopharmaceutical company developing innovative treatments based on a cell therapy. Subsequently it reverse-merged with Tigenix listed on Euronext. Tigenx was Acquired in July 2018 by Takeda Pharmaceuticals.